ERBB2 and breast carcinoma: During our investigation, greater than 50% of breast cancer specimens overexpressed PKCζ, and PKCζ that were related to pathological and prognostic characteristics, including clinical stage, lymph node metastasis status, tumor size, HER2 status and survival rate.